Abstract
Aim The coronavirus pandemic has led to significant challenges for healthcare delivery across the globe. Non-emergency endoscopic activity in the UK has been postponed, raising concerns of increased delays in the diagnosis of colorectal cancer and a surge in demand once services resume. Measures to mitigate this risk must be considered.
Method This paper reviews various investigative modalities for colorectal disease which could be deployed during cessation of colonoscopy services. We focus on
colon capsule endoscopy (CCE) due to its relevance during the COVID-19 pandemic and its ability to triage patients effectively to further endoscopic investigations.
Results CT of the abdomen and pelvis has been suggested as a triage tool while access to colonoscopy is limited. However, CT may lead to the spread of
COVID-19 as patients attend the hospital, and it exposes them to the risks of radiation. Faecal immunochemistry tests have been demonstrated as a good predictor of colonic pathology and could be safely used to risk stratify patients when prioritizing colonoscopy. CCE is a safe and innovative technology for investigating the colon. Procedures can be carried out in the community and can be conducted safely during the coronavirus pandemic. It has been shown to be an accurate detector of colonic neoplasia and can reduce demand for colonoscopy.
Conclusion As colonoscopy services resume, they will probably experience high demand leading to further delays for patients. CCE could be used to reduce the number of patients requiring colonoscopy and triage those requiring further endoscopic investigations appropriately.
Method This paper reviews various investigative modalities for colorectal disease which could be deployed during cessation of colonoscopy services. We focus on
colon capsule endoscopy (CCE) due to its relevance during the COVID-19 pandemic and its ability to triage patients effectively to further endoscopic investigations.
Results CT of the abdomen and pelvis has been suggested as a triage tool while access to colonoscopy is limited. However, CT may lead to the spread of
COVID-19 as patients attend the hospital, and it exposes them to the risks of radiation. Faecal immunochemistry tests have been demonstrated as a good predictor of colonic pathology and could be safely used to risk stratify patients when prioritizing colonoscopy. CCE is a safe and innovative technology for investigating the colon. Procedures can be carried out in the community and can be conducted safely during the coronavirus pandemic. It has been shown to be an accurate detector of colonic neoplasia and can reduce demand for colonoscopy.
Conclusion As colonoscopy services resume, they will probably experience high demand leading to further delays for patients. CCE could be used to reduce the number of patients requiring colonoscopy and triage those requiring further endoscopic investigations appropriately.
| Original language | English |
|---|---|
| Pages (from-to) | 621-624 |
| Number of pages | 4 |
| Journal | Colorectal Disease |
| Volume | 22 |
| Issue number | 6 |
| Early online date | 2 Jun 2020 |
| DOIs | |
| Publication status | Published - Jun 2020 |
Keywords
- Colon Capsule Endoscopy
- colonoscopy
- COVID-19
- Immunochemistry/methods
- Pandemics
- Humans
- Coronavirus Infections/epidemiology
- Colonoscopy/methods
- Triage/methods
- Colorectal Neoplasms/diagnosis
- Pneumonia, Viral/epidemiology
- Betacoronavirus
- Occult Blood
- Capsule Endoscopy/methods
- QUALITY
- ACCURACY
- POLYPS
- CT
- COLONOGRAPHY
- INDICATORS
Access to Document
- Macleod_et_al_CD_ColonCapsuleEndoscopy_AAM
This is the peer reviewed version of the following article: MacLeod, C., Wilson, P. and Watson, A.J.M. (2020), Colon capsule endoscopy: an innovative method for detecting colorectal pathology during the COVID‐19 pandemic?. Colorectal Dis, 22: 621-624., which has been published in final form at https://doi.org/10.1111/codi.15134. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.